Ventas (VTR)
(Real Time Quote from BATS)
$63.55 USD
-0.90 (-1.40%)
Updated Nov 14, 2024 12:20 PM ET
2-Buy of 5 2
D Value D Growth F Momentum F VGM
- YR Estimate
- 12/31/2023
- 12/31/2022
- 12/31/2021
- 12/31/2020
- 12/31/2019
- Revenue - Line of Business (LOBR)
- Revenues: Rental income: Triple-net leased
- 619.21
- 598.15
- 653.82
- 695.27
- 780.90
- Revenue - Line of Business (LOBR)
- Revenues: Rental income: Outpatient medical & research portfolio
- 867.19
- 801.16
- 794.30
- 799.63
- 828.98
- Revenue - Line of Business (LOBR)
- Revenues: Resident fees and services
- 2,959.22
- 2,651.89
- 2,270.00
- 2,197.16
- 2,151.53
- Revenue - Line of Business (LOBR)
- Revenues: Third party capital management revenues
- 17.84
- 26.20
- 20.10
- 15.19
- 11.16
- Revenue - Line of Business (LOBR)
- Revenues: Income from loans and investments
- 22.95
- 48.16
- 74.98
- 80.51
- 89.20
- Revenue - Line of Business (LOBR)
- Revenues: Interest and other income
- 11.41
- 3.64
- 14.81
- 7.61
- 10.98
- Income - Line of Business (LOBI)
- Net Earnings Per Share (Diluted)
- -0.10
- -0.12
- 0.13
- 1.17
- 1.17
- Income - Line of Business (LOBI)
- NOI: SHOP
- 711.41
- 647.47
- 458.27
- 538.49
- --
- Income - Line of Business (LOBI)
- NOI: Office Outpatient medical & research portfolio
- 576.93
- 546.60
- 543.88
- 549.38
- 574.16
- Income - Line of Business (LOBI)
- NOI: Triple-Net Leased Properties
- 604.65
- 582.85
- 638.49
- 673.11
- 754.34
- Expense - Line of Business (LOBE)
- Depreciation and amortization
- 1,392.46
- 1,197.80
- 1,197.40
- 1,109.76
- 1,045.62